| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 17, 2023 | Mar 21, 2023 | CHAMPIONS ONCOLOGY, INC. | CEO | Buy | 78.8 | +12,382 | 1.46% | ✗ | $50K |
| Mar 24, 2020 | Mar 26, 2020 | CHAMPIONS ONCOLOGY, INC. | CEO | Sell | 52.5 | -75 | -0.01% | ✗ | $393.8 |
| Mar 20, 2020 | Mar 24, 2020 | CHAMPIONS ONCOLOGY, INC. | CEO | Buy | 47.5 | +75 | 0.01% | ✗ | $356.3 |
| Dec 19, 2018 | Dec 20, 2018 | CHAMPIONS ONCOLOGY, INC. | CEO | Buy | 82.5 | +20,000 | 2.46% | ✗ | $148.8K |
| Mar 26, 2018 | Mar 28, 2018 | CHAMPIONS ONCOLOGY, INC. | CEO | Buy | 61.3 | +4,535 | 0.41% | ✗ | $16.3K |
| Mar 22, 2018 | Mar 26, 2018 | CHAMPIONS ONCOLOGY, INC. | CEO | Buy | 47.5 | +700 | 0.02% | ✗ | $2.4K |
| Oct 21, 2016 | Oct 24, 2016 | CHAMPIONS ONCOLOGY, INC. | President | Buy | 83.8 | +30,000 | 2.77% | ✗ | $49.9K |
| Oct 19, 2016 | Oct 20, 2016 | CHAMPIONS ONCOLOGY, INC. | President | Buy | 68.8 | +10,000 | 0.93% | ✗ | $17K |
| Oct 14, 2016 | Oct 17, 2016 | CHAMPIONS ONCOLOGY, INC. | President | Buy | 68.8 | +10,305 | 0.97% | ✗ | $17.1K |
| Oct 13, 2016 | Oct 14, 2016 | CHAMPIONS ONCOLOGY, INC. | President | Buy | 83.8 | +29,695 | 2.88% | ✗ | $49.5K |
| Oct 10, 2016 | Oct 11, 2016 | CHAMPIONS ONCOLOGY, INC. | President | Buy | 68.8 | +9,537 | 0.93% | ✗ | $15.8K |
| Sep 20, 2016 | Sep 21, 2016 | CHAMPIONS ONCOLOGY, INC. | President | Buy | 60.0 | +3,000 | 0.29% | ✗ | $4.7K |
| Mar 19, 2014 | Mar 21, 2014 | CHAMPIONS ONCOLOGY, INC. | President | Buy | 95.0 | +100,000 | 11.61% | ✗ | $107K |
| Jan 28, 2013 | Jan 30, 2013 | CHAMPIONS ONCOLOGY, INC. | President | Buy | 97.5 | +528,315 | 158.49% | ✗ | $250K |